Latticon Antibody Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Latticon Antibody Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) (NCT06277219) | Latticon Antibody Therapeutics, Inc | 2024-06-05 |
Track Latticon Antibody Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.